DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epivir (Lamivudine) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Epivir (Lamivudine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (204)
     Drug Exposure During Pregnancy (22)Anaemia (19)Immune Reconstitution Syndrome (13)more >>

Cases resulting in a serious event (203)
     Drug Exposure During Pregnancy (21)Anaemia (19)Immune Reconstitution Syndrome (13)more >>

Cases resulting in death (20)
     Pancytopenia (8)Malnutrition (4)Bone Marrow Failure (4)more >>

Cases resulting in life threatening events (27)
     Drug Eruption (4)Pulmonary Hypertension (4)Glucose Tolerance Impaired (4)more >>

Cases resulting in hospitalization (92)
     Anaemia (11)Dyspnoea (7)Vomiting (7)more >>

Cases resulting in disability (19)
     Renal Impairment (5)Drug Eruption (3)Glucose Tolerance Impaired (3)more >>

Cases resulting in other serious reactions (80)
     Anaemia (10)Abortion Spontaneous (8)Drug Exposure During Pregnancy (8)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Epivir (Lamivudine). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in female receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-10-29

Patient: female, weighing 9.2 kg (20.2 pounds)

Adverse reactions / side effects: Breech Delivery, Premature Baby, Congenital Anomaly, Patent Ductus Arteriosus, Joint Dislocation

Adverse event resulted in: hospitalization

Suspect drug(s):
Saquinavir
    Indication: HIV Infection

Nelfinavir
    Indication: HIV Infection
    Start date: 2003-03-12

Nelfinavir

Abacavir Sulfate
    Indication: HIV Infection

3TC
    Indication: HIV Infection

Nevirapine
    Indication: HIV Infection
    Start date: 2003-03-12

AZT
    Indication: HIV Infection

Epivir
    Indication: HIV Infection

Zidovudine
    Indication: HIV Infection
    Start date: 2003-03-12

Dexamethasone 0.5mg TAB
    Indication: Drug USE FOR Unknown Indication

Indomethacin
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Didanosine



Adverse event in male receiving Epivir (Lamivudine)

Reported by a physician on 2007-10-23

Patient: male, weighing 89.0 kg (195.8 pounds)

Adverse reactions / side effects: Drug Resistance

Suspect drug(s):
Viramune
    Dosage: 200mg during 14 days, thereafter 400mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21
    End date: 2007-07-30

Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-21
    End date: 2007-07-30

Other drugs received by patient: Glucovance; Eusaprim; Eusaprim



Adverse event in 39 year old female receiving Epivir (Lamivudine)

Reported by a pharmacist from United Kingdom on 2007-10-22

Patient: 39 year old female

Adverse reactions / side effects: Mitochondrial Cytopathy, Portal Vein Thrombosis, Hepatic Failure, Lactic Acidosis, Constipation

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-12-01

Indinivir Sulfate
    Indication: Drug USE FOR Unknown Indication

Nevirapine
    Dosage: 200mg twice per day
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Septrin



Adverse event in male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from Australia on 2007-10-22

Patient: male

Adverse reactions / side effects: Hepatitis

Adverse event resulted in: death

Suspect drug(s):
Hepsera
    Administration route: Oral
    Indication: Hepatitis B

Epivir
    Administration route: Oral
    Indication: Hepatitis B



Adverse event in female receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-10-19

Patient: female, weighing 0.9 kg (2.0 pounds)

Adverse reactions / side effects: Breech Delivery, Premature Baby, Congenital Anomaly, Patent Ductus Arteriosus, Joint Dislocation

Adverse event resulted in: hospitalization

Suspect drug(s):
Viracept
    Dosage: daily dose:2500mg-freq:daily
    Administration route: Oral
    Indication: HIV Infection

Ziagen
    Dosage: daily dose:600mg-freq:daily
    Administration route: Oral
    Indication: HIV Infection

3TC
    Indication: HIV Infection

Viramune
    Dosage: daily dose:400mg-freq:daily
    Indication: HIV Infection

Fortovase
    Dosage: daily dose:2400mg
    Administration route: Oral
    Indication: HIV Infection

AZT
    Indication: HIV Infection

Epivir
    Dosage: daily dose:300mg-freq:daily
    Indication: HIV Infection

Retrovir
    Dosage: daily dose:600mg-freq:daily
    Administration route: Oral
    Indication: HIV Infection
    End date: 2003-03-12

Dexamethasone 0.5mg TAB

Indocin

Other drugs received by patient: Videx



Adverse event in receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-10-19

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Hypospadias

Suspect drug(s):
Viracept
    Administration route: Oral
    Indication: HIV Infection

Videx

Sustiva

Epivir

Norvir

Retrovir

Indinivir Sulfate



Adverse event in receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from Australia on 2007-10-15

Patient:

Adverse reactions / side effects: Hepatitis

Adverse event resulted in: death

Suspect drug(s):
Hepsera
    Administration route: Oral
    Indication: Hepatitis B

Epivir
    Administration route: Oral
    Indication: Hepatitis B



Adverse event in 53 year old male receiving Epivir (Lamivudine)

Reported by a physician from United States on 2007-10-12

Patient: 53 year old male

Adverse reactions / side effects: Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased

Suspect drug(s):
Letairis
    Dosage: 5mg per day
    Administration route: Oral
    Start date: 2007-08-09
    End date: 2007-09-12

Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection

Spiriva

Viread
    Dosage: 300mg per day
    Indication: HIV Infection

Sustiva
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection

Other drugs received by patient: Lasix; Sildenafil Citrate; Warfarin Sodium; Advair Diskus 100 / 50; Singulair; Metformin HCL; Flomax; Wellbutrin



Adverse event in 37 year old female receiving Epivir (Lamivudine)

Reported by a physician from Italy on 2007-10-12

Patient: 37 year old female

Adverse reactions / side effects: Lactic Acidosis

Adverse event resulted in: life threatening event

Suspect drug(s):
Zerit
    Administration route: Oral
    Start date: 2006-07-04
    End date: 2007-05-05

Epivir
    Administration route: Oral
    Start date: 2006-07-04
    End date: 2007-05-05



Adverse event in 44 year old male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-10-11

Patient: 44 year old male

Adverse reactions / side effects: Optic Atrophy, Glaucoma, Optic Nerve Disorder, Drug Ineffective, Tooth Abscess, Trigeminal Neuralgia, Sciatica, Tooth Extraction, Visual Acuity Reduced, Treatment Noncompliance, Balance Disorder, Leukoencephalopathy, Depression, Optic Neuritis Retrobulbar, Facial Pain, Mononeuropathy Multiplex, Visual Disturbance, Gastrointestinal Disorder, Memory Impairment, Neuralgia

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Retrovir
    Indication: HIV Infection
    Start date: 2006-06-23

Telzir
    Indication: HIV Infection
    Start date: 2005-03-29
    End date: 2006-06-23

Combivir
    Indication: HIV Infection
    Start date: 2005-09-28
    End date: 2006-06-23

Epivir
    Indication: HIV Infection
    Start date: 1998-04-01

Viread
    Indication: HIV Infection
    Start date: 2006-06-23

Invirase
    Indication: HIV Infection
    Start date: 2006-06-23

Lyrica
    Indication: Trigeminal Neuralgia
    Start date: 2006-06-23
    End date: 2006-07-01

Neurontin
    Indication: Trigeminal Neuralgia
    Start date: 2006-01-01
    End date: 2006-01-01

Bactrim
    Start date: 1998-09-01

Norvir
    Indication: HIV Infection
    Start date: 2004-04-17

Other drugs received by patient: Viracept; Zerit



Adverse event in 44 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-10-11

Patient: 44 year old female

Adverse reactions / side effects: Jaundice, Liver Disorder

Suspect drug(s):
Epivir
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-01-01
    End date: 2007-01-01

Retrovir
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-01-01
    End date: 2007-01-01

Other drugs received by patient: Viracept



Adverse event in 45 year old male receiving Epivir (Lamivudine)

Reported by a physician from France on 2007-10-09

Patient: 45 year old male

Adverse reactions / side effects: Hypovitaminosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Sustiva

Epivir

Tenofovir



Adverse event in 45 year old male receiving Epivir (Lamivudine)

Reported by a physician from France on 2007-10-09

Patient: 45 year old male

Adverse reactions / side effects: Hypovitaminosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Sustiva

Epivir

Tenofovir



Adverse event in male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from Japan on 2007-10-08

Patient: male

Adverse reactions / side effects: Nausea, Diabetes Mellitus, Diarrhoea, Hypertriglyceridaemia, Liver Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection CDC Group IV Subgroup E
    Start date: 1998-11-24

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-11-24

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-11-24

Other drugs received by patient: Diovan



Adverse event in 44 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-10-03

Patient: 44 year old female

Adverse reactions / side effects: Jaundice, Liver Disorder

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Retrovir
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Viracept



Adverse event in 36 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-10-01

Patient: 36 year old male

Adverse reactions / side effects: Blood Urea Increased, AIDS Encephalopathy, Altered State of Consciousness, Blood Creatinine Increased, Renal Failure Chronic, Convulsion, Nephropathy

Adverse event resulted in: life threatening event

Suspect drug(s):
Ziagen
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2002-11-26
    End date: 2007-03-17

Viread
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2003-05-20
    End date: 2006-11-14

Epivir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-09-19
    End date: 2007-03-17

Retrovir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-09-19
    End date: 2006-12-11

Norvir
    Dosage: 100mg as directed
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-04-07
    End date: 2007-03-17

Norvir
    Dosage: 200mg unknown
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2003-05-20
    End date: 2003-11-10

Zithromax
    Administration route: Oral
    Indication: Opportunistic Infection Prophylaxis
    Start date: 2002-04-09

Baktar
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    Start date: 2006-04-01

Tipranavir
    Indication: Drug USE FOR Unknown Indication

Darunavir
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Unknown Drug; Unknown Drug



Adverse event in 61 year old male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-07-30

Patient: 61 year old male, weighing 62.0 kg (136.4 pounds)

Adverse reactions / side effects: Renal Tubular Disorder, Blood Creatine Phosphokinase Increased, Hyperkalaemia, Parkinsonism, Muscle Rigidity, Hyperuricaemia, Neuropathy Peripheral, Mitochondrial Cytopathy, Proteinuria, Blood Creatinine Increased, Acid Base Balance Abnormal, Pain in Extremity, Folate Deficiency, Akinesia, General Physical Health Deterioration, Paraesthesia, Anaemia Macrocytic, Renal Failure, Areflexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-15

Videx
    Dosage: 250mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-15

Zyprexa
    Dosage: 7.5mg per day
    Indication: Neuropathy

Other drugs received by patient: Reyataz; Norvir



Adverse event in 40 year old female receiving Epivir (Lamivudine)

Reported by a physician from France on 2007-07-30

Patient: 40 year old female

Adverse reactions / side effects: Hepatitis Cholestatic, Portal Hypertension, Hepatic Fibrosis, Lymphopenia, Varices Oesophageal, Lipodystrophy Acquired

Suspect drug(s):
Aprovel Tabs
    Administration route: Oral
    Indication: Hypertension
    End date: 2006-04-18

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-10-01
    End date: 2005-05-16

Epivir
    Indication: HIV Infection
    Start date: 2001-10-01

Viramune
    Indication: HIV Infection
    Start date: 2001-01-01

Viread
    Start date: 2005-03-16



Adverse event in 65 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-26

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Stocrin Caps
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Epivir
    Dosage: interrupted on 17-apr-2006 restarted on 18-apr-2006 at 300mg daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Abacavir Sulfate



Adverse event in 65 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-07-24

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Stocrin
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-18

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Simavastatin



Adverse event in 36 year old male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-07-23

Patient: 36 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Body Temperature Increased, Pleuritic Pain, Wheezing, Kaposi's Sarcoma, Pyrexia, Chest X-RAY Abnormal, Mycobacterium Avium Complex Infection, Acid Fast Bacilli Infection, Acute Respiratory Distress Syndrome, Crepitations, Sputum Culture Positive, Cough, Respiratory Rate Increased, Dyspnoea, Necrotising Granulomatous Lymphadenitis, Granuloma, Computerised Tomogram Abnormal, Human Herpesvirus 8 Infection, Bronchoalveolar Lavage Abnormal, Respiratory Failure, Inflammation

Adverse event resulted in: death

Suspect drug(s):
Epivir
    Indication: Kaposi's Sarcoma

Tenofovir Disoproxil Fumarate
    Indication: Kaposi's Sarcoma

Ritonavir (Formulation Unknown) (Ritonavir)
    Indication: Kaposi's Sarcoma

Atazanavir (Formulation Unknown) (Atazanavir)
    Indication: Kaposi's Sarcoma

Stealth Lip.doxorubicin (Formulation Unknown) (Stealth Lip.doxorubicin
    Indication: Kaposi's Sarcoma



Adverse event in 31 year old female receiving Epivir (Lamivudine)

Reported by a pharmacist from United Kingdom on 2007-07-19

Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)

Adverse reactions / side effects: Umbilical Cord Abnormality, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Didanosine
    Dosage: 250mg per day
    Administration route: Oral
    Indication: Retroviral Infection
    Start date: 2004-09-01

Norvir
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Fuzeon
    Dosage: 180mg per day
    Indication: Retroviral Infection

Reyataz
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Retroviral Infection

Valgancyclovir
    Indication: Cytomegalovirus Infection
    Start date: 2004-09-01

Other drugs received by patient: Cotrim



Adverse event in 27 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18

Patient: 27 year old female

Adverse reactions / side effects: Cholestasis of Pregnancy, Drug Exposure During Pregnancy, Proteus Infection, Anogenital Warts, Genital Infection

Suspect drug(s):
Combivir
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2005-02-16

Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Start date: 2004-07-29
    End date: 2005-02-16

Viread
    Dosage: 300mg per day
    Start date: 2004-07-29

Norvir
    Dosage: 400mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Fuzeon
    Dosage: 180mg per day
    Start date: 2005-03-22
    End date: 2005-03-31

Invirase
    Dosage: 2000mg per day
    Start date: 2004-09-29
    End date: 2005-02-16



Adverse event in male receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18

Patient: male, weighing 2.8 kg (6.2 pounds)

Adverse reactions / side effects: Diaphragmatic Hernia

Suspect drug(s):
Combivir
    Dosage: 900mg per day
    Start date: 2005-02-16

Epivir
    Dosage: 300mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Viread
    Dosage: 300mg per day
    Start date: 2004-07-29

Norvir
    Dosage: 400mg per day
    Start date: 2004-07-29
    End date: 2005-02-16

Fuzeon
    Dosage: 180mg per day
    Start date: 2005-03-22
    End date: 2005-03-31

Invirase
    Dosage: 2000mg per day
    Start date: 2004-09-29
    End date: 2005-02-16



Adverse event in 2 month old male receiving Epivir (Lamivudine)

Reported by a physician from France on 2007-07-16

Patient: 2 month old male

Adverse reactions / side effects: Gastrointestinal Malformation, Heart Disease Congenital, Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Videx
    Start date: 2001-06-12
    End date: 2001-08-11

Retrovir
    Start date: 2001-03-27
    End date: 2001-08-11

Epivir
    Start date: 2001-03-27
    End date: 2001-08-11

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009